Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.7 - $1.4 $48,873 - $97,746
-69,819 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.63 - $1.59 $11,382 - $28,728
-18,068 Reduced 20.56%
69,819 $90,000
Q4 2021

Feb 15, 2022

SELL
$1.27 - $2.42 $166,930 - $318,087
-131,441 Reduced 59.93%
87,887 $112,000
Q3 2021

Nov 15, 2021

BUY
$2.15 - $3.82 $12,521 - $22,247
5,824 Added 2.73%
219,328 $478,000
Q2 2021

Aug 16, 2021

SELL
$2.89 - $4.45 $11,583 - $17,835
-4,008 Reduced 1.84%
213,504 $801,000
Q1 2021

May 18, 2021

SELL
$2.9 - $4.09 $2,276 - $3,210
-785 Reduced 0.36%
217,512 $709,000
Q3 2020

Nov 17, 2020

BUY
$2.99 - $4.9 $140,296 - $229,917
46,922 Added 27.38%
218,297 $891,000
Q1 2020

May 13, 2020

BUY
$1.83 - $3.45 $3,632 - $6,848
1,985 Added 1.17%
171,375 $399,000
Q4 2019

Feb 14, 2020

SELL
$3.5 - $10.35 $19,621 - $58,022
-5,606 Reduced 3.2%
169,390 $617,000
Q3 2019

Nov 15, 2019

BUY
$7.03 - $9.7 $23,473 - $32,388
3,339 Added 1.95%
174,996 $1.45 Million
Q2 2019

Aug 14, 2019

BUY
$7.36 - $11.26 $118,797 - $181,747
16,141 Added 10.38%
171,657 $1.48 Million
Q1 2019

May 09, 2019

SELL
$9.08 - $11.84 $21,919 - $28,581
-2,414 Reduced 1.53%
155,516 $1.66 Million
Q4 2018

Feb 13, 2019

BUY
$6.39 - $16.99 $23,438 - $62,319
3,668 Added 2.38%
157,930 $1.38 Million
Q3 2018

Nov 14, 2018

BUY
$16.52 - $24.82 $44,901 - $67,460
2,718 Added 1.79%
154,262 $2.59 Million
Q2 2018

Aug 14, 2018

BUY
$14.31 - $21.75 $274,895 - $417,817
19,210 Added 14.52%
151,544 $3.18 Million
Q1 2018

May 15, 2018

SELL
$16.09 - $23.07 $74,641 - $107,021
-4,639 Reduced 3.39%
132,334 $2.13 Million
Q4 2017

Feb 14, 2018

BUY
$13.36 - $20.73 $165,263 - $256,430
12,370 Added 9.93%
136,973 $2.6 Million
Q3 2017

Nov 13, 2017

BUY
$8.75 - $14.07 $1.09 Million - $1.75 Million
124,603
124,603 $1.75 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.